Search research articles
Contact Us
Filters
Showing results (861-870 of 940) with videos related to
Page
of 94
Sort By:
Molecular Cancer Therapeutics
|
October 22, 2017
Discovery of a Highly Selective NAMPT Inhibitor That Demonstrates Robust Efficacy and Improved Retinal Toxicity with Nicotinic Acid Coadministration
Genshi Zhao, Colin F Green, Yu-Hua Hui, et al.
Chest
|
November 14, 2006
Feasibility of retinoids for the treatment of emphysema study
Michael D Roth, John E Connett, Jeanine M D'Armiento, et al.
Arthritis and Rheumatism
|
February 5, 2005
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study
Dinesh Khanna, Philip J Clements, Daniel E Furst, et al.
International Journal of Obesity (2005)
|
November 26, 2009
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight
C M Mack, C J Soares, J K Wilson, et al.
Clinical and Translational Radiation Oncology
|
February 16, 2026
Late toxicity after peposertib-enhanced chemoradiation in rectal cancer patients managed with organ preservation
W Zambare, R Ravella, C Li, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 22, 2020
Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung Disease
Shervin Assassi, Ning Li, Elizabeth R Volkmann, et al.
Respiratory Research
|
November 21, 2009
Eosinophil and T cell markers predict functional decline in COPD patients
Jeanine M D'Armiento, Steven M Scharf, Michael D Roth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 15, 2019
The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer Immunotherapy
David A Schaer, Sandaruwan Geeganage, Nelusha Amaladas, et al.
Journal of Medicinal Chemistry
|
October 27, 2017
Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft Model
Kevin R Fales, F George Njoroge, Harold B Brooks, et al.
The New England Journal of Medicine
|
June 23, 2006
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P Tashkin, Robert Elashoff, Philip J Clements, et al.
Page
of 94
Search research articles
Search
Showing results (861-870 of 940) with videos related to
Sort By:
Page
of 94
Molecular Cancer Therapeutics
|
October 22, 2017
Discovery of a Highly Selective NAMPT Inhibitor That Demonstrates Robust Efficacy and Improved Retinal Toxicity with Nicotinic Acid Coadministration
Genshi Zhao, Colin F Green, Yu-Hua Hui, et al.
Chest
|
November 14, 2006
Feasibility of retinoids for the treatment of emphysema study
Michael D Roth, John E Connett, Jeanine M D'Armiento, et al.
Arthritis and Rheumatism
|
February 5, 2005
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study
Dinesh Khanna, Philip J Clements, Daniel E Furst, et al.
International Journal of Obesity (2005)
|
November 26, 2009
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight
C M Mack, C J Soares, J K Wilson, et al.
Clinical and Translational Radiation Oncology
|
February 16, 2026
Late toxicity after peposertib-enhanced chemoradiation in rectal cancer patients managed with organ preservation
W Zambare, R Ravella, C Li, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 22, 2020
Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung Disease
Shervin Assassi, Ning Li, Elizabeth R Volkmann, et al.
Respiratory Research
|
November 21, 2009
Eosinophil and T cell markers predict functional decline in COPD patients
Jeanine M D'Armiento, Steven M Scharf, Michael D Roth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 15, 2019
The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer Immunotherapy
David A Schaer, Sandaruwan Geeganage, Nelusha Amaladas, et al.
Journal of Medicinal Chemistry
|
October 27, 2017
Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft Model
Kevin R Fales, F George Njoroge, Harold B Brooks, et al.
The New England Journal of Medicine
|
June 23, 2006
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P Tashkin, Robert Elashoff, Philip J Clements, et al.
Page
of 94